Business Context and Reporting Period
This Form 8-K, dated December 19, 2023, reports the consummation of a business combination between Chavant Capital Acquisition Corp. (a Cayman Islands SPAC) and Mobix Labs, Inc. The transaction closed on December 21, 2023. Following the merger, the registrant changed its name from "Chavant Capital Acquisition Corp." to "Mobix Labs, Inc." and is now a Delaware corporation. The company trades on the Nasdaq Global Market under the symbol "MOBX" and on the Nasdaq Capital Market for warrants under "MOBXW."
Key Financial Metrics and Capital Structure
The filing details significant capital raises and debt restructuring rather than operating financial metrics like revenue or profit, which are not provided in this document.
- PIPE Investment (Cash): Sage Hill Investors, LLC invested $15.0 million for 1,500,000 shares. Other investors contributed $4.75 million for 475,000 shares. Total cash PIPE: $19.75 million.
- Sponsor PIPE (Debt Forgiveness): The Sponsor (Chavant Capital Partners LLC) invested approximately $2.0 million (199,737 shares) via the forgiveness of outstanding indebtedness and reimbursement obligations owed by the company.
- Debt Relief: Approximately $1,997,370 of obligations were forgiven, including $1.15 million in convertible promissory notes, $610,000 in non-convertible notes, and various administrative reimbursement obligations.
- Redemptions: Shareholders holding 667,907 ordinary shares exercised their right to redeem shares for a pro rata portion of the trust account funds, disbursed on December 22, 2023.
- Non-Redemption: One shareholder withdrew a redemption election for 73,706 shares in exchange for warrants that converted into 202,489 shares of Class A Common Stock.
Material Changes Versus Prior Period
The primary material change is the corporate restructuring and capitalization resulting from the SPAC merger:
- Corporate Identity: Transition from a Cayman Islands exempted company to a Delaware corporation.
- Equity Structure: Issuance of new Class A Common Stock to PIPE investors and conversion of warrants into common stock.
- Debt Reduction: Elimination of approximately $2.0 million in working capital loans and administrative obligations owed to the Sponsor.
- Shareholder Base: Reduction in outstanding shares due to redemptions, offset by new issuances to PIPE investors and warrant conversions.
Guidance, Outlook, and Risks
The filing does not contain forward-looking financial guidance, revenue projections, or management commentary on future operating performance. Key contingencies and unusual items include:
- Warrant Exercise Contingency: Certain warrants issued to Sage Hill Investors (1,500,000 shares) and Other Investors (250,000 shares) are exercisable only upon obtaining stockholder approval, which is expected in 2024.
- Lock-Up Agreements: Founder Shares held by the Sponsor are subject to a lock-up agreement. The Sponsor forfeited 658,631 Founder Shares and 400,000 Private Warrants as part of the transaction terms.
- Unregistered Securities: Certain securities were issued under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, subject to resale restrictions.
Important Facts for Investor Verification
- Verify the exact number of shares outstanding post-closing, accounting for redemptions, PIPE issuances, and warrant conversions.
- Confirm the status of the stockholder approval required in 2024 for the exercise of the "Unregistered Warrant Shares" (Sage Hill and Non-Converted Additional Warrants).
- Review the specific terms of the lock-up agreements applicable to the Sponsor's remaining Founder Shares and Private Warrants.
- Check the cash balance remaining in the trust account after the redemption of 667,907 shares to assess immediate liquidity.
- Examine the definitive proxy statement/prospectus for detailed definitions of "Forgiven Chavant Obligations" and the specific allocation of shares to Dr. Jiong Ma and Dr. André-Jacques Auberton-Hervé.